Catheter-related Infection Clinical Trial
Official title:
Optimalisation of Therapeutic Drug Monitoring (TDM) of Vancomycin in Patients With Central Venous Port Devices
Recently, it was reported that when vancomycin levels are determined after port sampling,
levels can be falsely increased potentially leading to wrong dose adjustments.
The investigators conducted an in vitro experiment using several central venous port
devices, in which different flushing techniques were evaluated yielding residual vancomycin
levels of less than 0.5 mg/L.
In this study, the investigators want to evaluate this flushing technique in vivo in 15
patients admitted with catheter-related infection and treated with systemic vancomycin and
vancomycin antibiotic lock.
The purpose is to assess if correct flushing can avoid spurious vancomycin levels obtained
via port sampling.
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00633061 -
Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer
|
Phase 2 |